BL- IMMUNOMODULATOR Flashcards

1
Q

By________we mean the use of drugs, alone or in combination with other maneuvers, to change the function of all, or part, of the immune system

A

immunomodulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Immunomodulation Main categories

A
  1. Non-steroidal anti-inflammatory drugs (NSAIDs).
  2. Disease-modifying antirheumatic drugs (DMARDs).
  3. Glucocorticoids.
  4. Biological response modifiers.
  5. Tumor-specific monoclonal antibodies.
  6. Other antibodies.
  7. Miscellaneous drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The typical monoclonal antibody derives from the progeny of a single B cell, that has been fused with a multiple myeloma tumor cell; the resultant hybrid line can grow forever in culture like its tumor parent, but make the _______of its B cell parent.

A

specific antibody

~ 33 are already drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The first monoclonals were made using B cells directly derived from immunized mice; such antibodies are:

A

murine (mice)- e.g., ibritumomab

Most are made this way

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Monoclonal Antibodies definition

A

monospecific antibodies that are made by identical immune cells that are all clones of a unique parent cell, in contrast to polyclonal antibodies which are made from several different immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mouse Multiple Myeloma

A

These cells make antibodies and live “forever”

Now we can transform these (genetically) to make monoclonal ABs and be immortal

  • We deleted its light and heavy chain
  • We “fused” m.m.m w/ the cell we wanted creating a hybrid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

These are all examples of:

Non-steroidal anti-inflammatory drugs (NSAIDs). Disease-modifying antirheumatic drugs (DMARDs). Glucocorticoids. Biological response modifiers.Tumor-specific monoclonal antibodies. Other antibodies.

A

Immunomodulation Main categories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

There are monoclonals which are ______-zumab

A

humanized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

We deleted its light and heavy chain

We “fused” m.m.m w/ the cell we wanted creating a hybrid

Why do this?

A

How we use Mouse Mult. Myeloma to make monoclonal ab’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Many of these agents are antibodies to various components of the immune or inflammatory system (which stimulate, inhibit, or opsonize, depending on the designer’s intentions).

A

BIOLOGICAL RESPONSE MODIFIERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Do you use a B cell mmm hybride that sees self and tumor cell?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hybridoma

A

is a technology of forming hybrid cell lines (called hybridomas) by fusing an antibody-producing B cell with a myeloma (B cell cancer) cell that is selected for its ability to grow in tissue culture and for an absence of antibody chain synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antibody to_______should be useful, and quite a few monoclonal antibodies (mAb) are already available

A

tumor-associated antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Do you use a B cell/mmm hybride that sees tumor cells but not self?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Essential anti-inflammatories in transplantation. Usually start with very high
dose, taper as soon as possible; discontinue if possible. High doses can also be used briefly for threatened rejection episodes.

A

Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

is a technology of forming hybrid cell lines (called hybridomas) by fusing an antibody-producing B cell with a myeloma (B cell cancer) cell that is selected for its ability to grow in tissue culture and for an absence of antibody chain synthesis.

A

Hybridoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

agent decreases DNA synthesis and mRNA

transcription. It is gradually being replaced

A

Azathioprine (related to 6-mecaptopurine):

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

primary function is to decrease IL-2 production. Thus it is synergistic with
glucocorticoids which, by down-regulating macrophage function as APCs, lessen stimulation of
T cells.

A

Cyclosporine-A

19
Q

What is the problem with mouse monoclonal antibodies?

A

We react to the mouse protein
Make AB against it
So its better for one time use
(good for like transplants!)

20
Q

drug is less toxic and has the same mode of action as azathioprine

A

Mycophenolate mofetil.

21
Q

How can we improve mouse monoclonal antibodies so they can be used more than once?

A

Only need the variable region of the AB

Replace all else with human protein

Accomplish this with gene inserion into the Hybridoma

Creates Chimeric

*Can be used more than once

22
Q

HACA

A

Human anti-chimeric antibody. Eventually deveples against Chimeric

23
Q

Humanized monoclonal antibody only maintains ____ from the mouse antibody

A

CDR

24
Q

Only need the variable regionof the AB

Replace all else with human protein

Accomplish this with gene inserion into the Hybridoma

Creates______

A

Chimeric

25
Q

HAHA

A

forms against humanized antibodies

26
Q

Humira

A

Human antibody against tnf-alpha- Treats arthritis, ankylosing spondylitis, Crohn disease, or similar problems.

27
Q

Humira is made by

A

Mouse with SCID given human thymus, bone marrow, and lymph mode. B cell against tnf-alpha found and used

28
Q

-umab

A

Human monoclonal ab

29
Q

-zumab

A

humanized monoclonal ab

30
Q

Fully human mAb to TNFα. It has been shown to slow the progress of RA, and thus is a BRM and a DMARD, technically. Approvals: RA, JRA, psoriatic arthritis, ankylosing spondylitis, Crohn, ulcerative colitis, psoriasis

A

Humira

31
Q

-ximab

A

Chimeric

32
Q

Anti-IL-6 receptor. For use in ____when response to DMARDs is inadequate.

A

RA

33
Q

Chimeric mAb to CD20. Used to treat non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. For RA when anti-TNF therapy fails, and for Wegener’s granulomatosis. Off-label for MS.

A

rituximab

34
Q

_______cells are large granular lymphocytes (LGL) which make up 5-10% of blood lymphocytic cells, with mechanisms available similar to those of CTL, but they
do not have rearranged V(D)J genes and are not thymic-derived

A

NK (natural killer)

35
Q

_______ are a type of cytotoxic lymphocyte critical to the innate immune system. Their role is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response.

A

Natural killer cells or NK cells

36
Q

NK cells can kill ______ cells, although you have never been exposed

A

Tumor cells, by virtue of their oddness

37
Q

NK cells have _____ in the cytoplasm

A

GRANULES

38
Q

NK (natural killer) cells are LARGE granular lymphocytes (LGL) which make up 5-10% of blood lymphocytic cells, with mechanisms available similar to those of CTL, but they
do not have________ genes and are not thymic-derived

A

rearranged V(D)J

39
Q

NK cells are part of the _____ immune system

A

innate

40
Q

NK cells have receptors that attract them to

A

damaged or stressed cells, like tumor cells

NK killing

41
Q

NK has receptors for

A

the Fc portion of ABs

Antibody-dependent cell-mediated cytotoxicity, or ADCC

42
Q

few NK receptors which recognize molecules on the surface of ‘stressed’ or dysregulated cells, such as virally infected cells or many tumors, which they then kill; therefore, they are part of the:

A

innate immune system

43
Q

ADCC works because NK cells also have receptors for the Fc end of IgG (FcγR), and so they have an _______way to interact with target cells.

A

antibody-dependent